<?xml version="1.0"?>
<rss version="2.0" xmlns:geo="http://www.w3.org/2003/01/geo/wgs84_pos#" xmlns:content="http://purl.org/rss/1.0/modules/content/" xmlns:media="http://search.yahoo.com/mrss/" xmlns:yt="http://gdata.youtube.com/schemas/2007" xmlns:atom="http://www.w3.org/2005/Atom">
   <channel>
      <title>SDBN Blog News Current</title>
      <description>Feeds to Twitter
3/9/15 Filtered out Florida, &quot;presenting&quot; items
10/27/2014 Now able to filter out LA Biospace feed, changed/added
10/17/2014 Added PR newswire feed
8/6/2014 Blocked more Biospace content
7/24/2014 Blocked more Biospace content
6/20/14 Removed SDBN blog feed and added directly to Feedblitz as articles weren&amp;#39;t showing up in emails
6/15/2014 Created filter to block post dated items
5/20/2014 removed html and special characters from titles
5/14/2014 Added Biospace, tried to filter out OC/LA
5/9/2014 moved BIO to be filtered for San Diego news only
3/27/14: Added BIO and updated SDUT and Marketwired feeds</description>
      <link>http://pipes.yahoo.com/pipes/pipe.info?_id=7b2240a3e401a07252c475773d8928a5</link>
      <atom:link rel="next" href="http://pipes.yahoo.com/pipes/pipe.run?_id=7b2240a3e401a07252c475773d8928a5&amp;_render=rss"/>
      <pubDate>Thu, 01 Oct 2015 22:52:08 +0000</pubDate>
      <generator>http://pipes.yahoo.com/pipes/</generator>
      <item>
         <title>FORCE11 Funds UC San Diego to Develop ’Scholarly Commons’ of the Future</title>
         <link>http://ucsdnews.ucsd.edu/pressrelease/force11_funds_uc_san_diego_to_develop_scholarly_commons_of_the_future</link>
         <description>&lt;p&gt;&lt;img style=&quot;float:left;margin:0 20px 10px 0;&quot; src=&quot;http://ucsdnews.ucsd.edu/news_uploads/maryann-martone-151001-t.jpg&quot;/&gt;&lt;/p&gt;
      								&lt;p&gt;The grant will fund two workshops and supporting materials that explore how to advance scholarly communication in a world where scholarship goes beyond written text to include software code, workflows, data and databases.</description>
         <guid isPermaLink="false">http://ucsdnews.ucsd.edu/pressrelease/force11_funds_uc_san_diego_to_develop_scholarly_commons_of_the_future#When:21:40:00Z</guid>
         <pubDate>Thu, 01 Oct 2015 21:40:00 +0000</pubDate>
         <enclosure type="image/jpeg" url="http://ucsdnews.ucsd.edu/news_uploads/maryann-martone-151001-t.jpg"/>
      </item>
      <item>
         <title>Fatty Liver Disease and Scarring Have Strong Genetic Component</title>
         <link>http://ucsdnews.ucsd.edu/pressrelease/fatty_liver_disease_and_scarring_have_strong_genetic_component</link>
         <description>&lt;p&gt;&lt;img style=&quot;float:left;margin:0 20px 10px 0;&quot; src=&quot;http://ucsdnews.ucsd.edu/news_uploads/steatohepatitis-151001-t.jpg&quot;/&gt;&lt;/p&gt;
      								&lt;p&gt;Researchers at the University of California, San Diego School of Medicine say that hepatic fibrosis, which involves scarring of the liver that can result in dysfunction and, in severe cases, cirrhosis and cancer, may be as much a consequence of genetics as environmental factors.</description>
         <guid isPermaLink="false">http://ucsdnews.ucsd.edu/pressrelease/fatty_liver_disease_and_scarring_have_strong_genetic_component#When:20:24:00Z</guid>
         <pubDate>Thu, 01 Oct 2015 20:24:00 +0000</pubDate>
         <enclosure type="image/jpeg" url="http://ucsdnews.ucsd.edu/news_uploads/steatohepatitis-151001-t.jpg"/>
      </item>
      <item>
         <title>Wave Vibrations Shaking Antarctic Ice Shelves</title>
         <link>http://ucsdnews.ucsd.edu/pressrelease/wave_vibrations_shaking_antarctic_ice_shelves</link>
         <description>&lt;p&gt;&lt;img style=&quot;float:left;margin:0 20px 10px 0;&quot; src=&quot;http://ucsdnews.ucsd.edu/news_uploads/seismic-station-151001-t.jpg&quot;/&gt;&lt;/p&gt;
      								&lt;p&gt;Scripps Oceanography researchers release early results of a seismic survey that shows how wave energy from as far away as the North Pacific Ocean shakes ice shelves in Antarctica and contributes to their breakup and collapse.</description>
         <guid isPermaLink="false">http://ucsdnews.ucsd.edu/pressrelease/wave_vibrations_shaking_antarctic_ice_shelves#When:16:54:00Z</guid>
         <pubDate>Thu, 01 Oct 2015 16:54:00 +0000</pubDate>
         <enclosure type="image/jpeg" url="http://ucsdnews.ucsd.edu/news_uploads/seismic-station-151001-t.jpg"/>
      </item>
      <item>
         <title>Coral’s Delayed Reaction to Devastating Effects of an Oil Spill</title>
         <link>http://ucsdnews.ucsd.edu/pressrelease/corals_delayed_reaction_to_devastating_effects_of_an_oil_spill</link>
         <description>&lt;p&gt;&lt;img style=&quot;float:left;margin:0 20px 10px 0;&quot; src=&quot;http://ucsdnews.ucsd.edu/news_uploads/Coral-Spawning-t.jpg&quot;/&gt;&lt;/p&gt;
      								&lt;p&gt;Coral reefs in the Caribbean have been declining for decades, largely as a result of development, overfishing, and disease. An April 2012 oil spill threatened to further harm this fragile ecosystem on the island of Curaçao, as oil blanketed an area roughly the size of thirty soccer fields.</description>
         <guid isPermaLink="false">http://ucsdnews.ucsd.edu/pressrelease/corals_delayed_reaction_to_devastating_effects_of_an_oil_spill#When:16:11:00Z</guid>
         <pubDate>Thu, 01 Oct 2015 16:11:00 +0000</pubDate>
         <enclosure type="image/jpeg" url="http://ucsdnews.ucsd.edu/news_uploads/Coral-Spawning-t.jpg"/>
      </item>
      <item>
         <title>A snake's penis develops with limb DNA</title>
         <link>http://www.sandiegouniontribune.com/news/2015/oct/01/snake-limb-penis-genetic/</link>
         <description>Genetic control element that helps form limbs also contributes to penis, study finds.</description>
         <guid isPermaLink="false">http://www.sandiegouniontribune.com/news/2015/oct/01/snake-limb-penis-genetic/</guid>
         <pubDate>Thu, 01 Oct 2015 16:00:00 +0000</pubDate>
      </item>
      <item>
         <title>Elcelyx Raises $40M, Begins Late-Stage Trial of New Diabetes Drug</title>
         <link>http://feedproxy.google.com/~r/Xconomy_San_Diego_Life_Sciences/~3/qxITw8awcmI/</link>
         <guid isPermaLink="false">http://www.xconomy.com/?p=310120</guid>
         <pubDate>Thu, 01 Oct 2015 12:34:32 +0000</pubDate>
         <content:encoded><![CDATA[San Diego-based Elcelyx Therapeutics said today it has secured $40 million in a Series E financing&#8212;its biggest ever&#8212;after receiving official guidance from the FDA for late-stage trials of...<br/>
<br/>
[[Click headline to continue reading.]]<img src="http://feeds.feedburner.com/~r/Xconomy_San_Diego_Life_Sciences/~4/qxITw8awcmI" height="1" width="1" alt=""/>]]></content:encoded>
      </item>
      <item>
         <title>SoCal's Elcelyx Therapeutics Reels in $40 Million</title>
         <link>http://www.biospace.com/news_story.aspx?StoryID=393364&amp;full=1</link>
         <description>&lt;font&gt;&lt;b&gt;Elcelyx Therapeutics Announces $40 Million Series E Financing&lt;/font&gt;&lt;/b&gt;&lt;br&gt;&lt;br&gt;&lt;b&gt;Company Enrolling Phase 2b Trial of Metformin Delayed Release for Type 2 Diabetes&lt;/b&gt;&lt;br&gt;&lt;p&gt;SAN DIEGO, Oct. 1, 2015 /PRNewswire/ -- Elcelyx Therapeutics has raised $40 million in a Series E financing following receipt of guidance from the U.S. Food and Drug Administration regarding the late...</description>
         <guid isPermaLink="false"></guid>
         <pubDate>Thu, 01 Oct 2015 00:00:00 +0000</pubDate>
      </item>
      <item>
         <title>Orexigen Announces Submission Of Contrave New Drug Application In South Korea</title>
         <link>http://www.biospace.com/news_story.aspx?StoryID=393399&amp;full=1</link>
         <description>&lt;div&gt;&lt;p&gt;&lt;span&gt;SAN DIEGO&lt;/span&gt;, &lt;span&gt;Oct. 1, 2015&lt;/span&gt; /PRNewswire/ -- Orexigen Therapeutics, Inc. (Nasdaq: OREX) today announced that Kwang Dong Pharmaceutical Company, Ltd., has filed a New Drug Application with the Ministry of Food and Drug Safety (MFDS) in &lt;span&gt;South Korea&lt;/span&gt; for Contrave&lt;sup&gt;&lt;/sup&gt; (naltrexone...&lt;/div&gt;</description>
         <guid isPermaLink="false"></guid>
         <pubDate>Thu, 01 Oct 2015 00:00:00 +0000</pubDate>
      </item>
      <item>
         <title>AntiCancer Announces New Technology For Growing Hair In Long-Term Culture</title>
         <link>http://www.biospace.com/news_story.aspx?StoryID=393544&amp;full=1</link>
         <description>&lt;div&gt;&lt;p&gt;SAN DIEGO--(&lt;a rel=&quot;nofollow&quot;&gt;BUSINESS WIRE&lt;/a&gt;)--&lt;a rel=&quot;nofollow&quot;&gt;AntiCancer       Inc.&lt;/a&gt; has announced...&lt;/div&gt;</description>
         <guid isPermaLink="false"></guid>
         <pubDate>Thu, 01 Oct 2015 00:00:00 +0000</pubDate>
      </item>
      <item>
         <title>Apricus Biosciences And Ferring Pharmaceuticals Sign Exclusive Distribution Agreement To Market Topical Erectile Dysfunction Cream Vitaros In Latin American Countries</title>
         <link>http://www.biospace.com/news_story.aspx?StoryID=393425&amp;full=1</link>
         <description>&lt;p&gt;SAN DIEGO, Oct. 1, 2015 (GLOBE NEWSWIRE) -- Apricus Biosciences, Inc. (Nasdaq:APRI), a biopharmaceutical company advancing innovative medicines in urology and rheumatology, today announced that it has signed an exclusive distribution agreement with Ferring Pharmaceuticals (&quot;Ferring&quot;) to market Vitaros...</description>
         <guid isPermaLink="false"></guid>
         <pubDate>Thu, 01 Oct 2015 00:00:00 +0000</pubDate>
      </item>
      <item>
         <title>Illumina Expands World???s Largest Genomics Analysis Platform And Adds To Open Source Initiative</title>
         <link>http://www.businesswire.com/portal/site/biospace/template.PAGE/menuitem.ab520ce17e34ab71ff00d635c0908a0c/index.jsp?ndmViewId=news_view&amp;newsId=20151001005517&amp;newsLang=en</link>
         <description>SAN DIEGO--(BUSINESS WIRE)--Illumina, Inc. (NASDAQ: ILMN) today announced several new additions to BaseSpacethe worlds largest and most comprehensive cloud computing environmentwith the launch of BaseSpace Professional and Enterprise Editions, fully integrated Laboratory Information Management System (LIMS) solutions and advanced infrastructure upgrades.&lt;br&gt;&lt;br&gt;Help employers find you! Check out...</description>
         <guid isPermaLink="false"></guid>
         <pubDate>Thu, 01 Oct 2015 00:00:00 +0000</pubDate>
      </item>
      <item>
         <title>Neurocrine Biosciences Announces The Appointment Of To Its Board Of Directors</title>
         <link>http://www.biospace.com/news_story.aspx?StoryID=393386&amp;full=1</link>
         <description>&lt;div&gt;&lt;p&gt;&lt;span&gt;SAN DIEGO&lt;/span&gt;, &lt;span&gt;Sept. 30, 2015&lt;/span&gt; /PRNewswire/ --Neurocrine Biosciences, Inc. (NASDAQ: NBIX) announced today that it has appointed &lt;span&gt;George J. Morrow&lt;/span&gt; to its Board of Directors. Mr. Morrow has over three decades of global pharmaceutical commercial operations leadership experience with Amgen...&lt;/div&gt;</description>
         <guid isPermaLink="false"></guid>
         <pubDate>Thu, 01 Oct 2015 00:00:00 +0000</pubDate>
      </item>
      <item>
         <title>Mo Bio Laboratories, Inc. Launches New, Redesigned Website</title>
         <link>http://www.biospace.com/news_story.aspx?StoryID=393464&amp;full=1</link>
         <description>&lt;div&gt;&lt;p&gt;&lt;span&gt;CARLSBAD, Calif.&lt;/span&gt;, &lt;span&gt;Oct. 1, 2015&lt;/span&gt; /PRNewswire/ -- MO BIO Laboratories, Inc., the leader in soil, stool and microbial nucleic acid purification, announces the launch of the redesign of its website, &lt;a rel=&quot;nofollow&quot;&gt;www.mobio.com&lt;/a&gt;.&lt;/p&gt;&lt;/div&gt;</description>
         <guid isPermaLink="false"></guid>
         <pubDate>Thu, 01 Oct 2015 00:00:00 +0000</pubDate>
      </item>
      <item>
         <title>Amoy Diagnostics, Illumina Team Up to Discover Next-Gen Sequencing Cancer Diagnostics in China</title>
         <link>http://www.biospace.com/news_story.aspx?StoryID=393408&amp;full=1</link>
         <description>&lt;font&gt;&lt;b&gt;Amoy Diagnostics and Illumina Enter Strategic Collaboration for Next-Generation Sequencing Cancer Diagnostics in China &lt;/font&gt;&lt;/b&gt;&lt;br&gt;&lt;div&gt;&lt;p&gt;XIAMEN, China &amp; SAN DIEGO--(&lt;a rel=&quot;nofollow&quot;&gt;BUSINESS WIRE&lt;/a&gt;)--Amoy Diagnostics Co. Ltd. (ADx) and Illumina, Inc. (NASDAQ: ILMN) today       announced a strategic collaboration to accelerate the...&lt;/div&gt;</description>
         <guid isPermaLink="false"></guid>
         <pubDate>Thu, 01 Oct 2015 00:00:00 +0000</pubDate>
      </item>
      <item>
         <title>REVA Medical Completes Clinical Enrollment Milestone</title>
         <link>http://www.biospace.com/news_story.aspx?StoryID=393487&amp;full=1</link>
         <description>SAN DIEGO, Sept. 30, 2015 (GLOBE NEWSWIRE) -- REVA Medical, Inc. (ASX:RVA) is pleased to announce that it has enrolled the first cohort of 110 patients in the FANTOM II clinical trial. Achievement of this milestone is key to the Companys planned CE Mark application of its Fantom sirolimus-eluting bioresorbable scaffold. The CE Mark application, planned for mid-2016, will be based upon data from these...</description>
         <guid isPermaLink="false"></guid>
         <pubDate>Thu, 01 Oct 2015 00:00:00 +0000</pubDate>
      </item>
      <item>
         <title>OncoSec Medical Inc. To Host Fourth Quarter Financial Results Conference Call And Live Webcast On October 15, 2015</title>
         <link>http://www.biospace.com/news_story.aspx?StoryID=393434&amp;full=1</link>
         <description>&lt;div&gt;&lt;p&gt;&lt;span&gt;SAN DIEGO&lt;/span&gt;, &lt;span&gt;Oct. 1, 2015&lt;/span&gt; /PRNewswire/ -- OncoSec Medical Incorporated (&quot;OncoSec&quot;) (NASDAQ: ONCS), a company developing DNA-based intratumoral cancer immunotherapies, today announced that the Company will host its fiscal fourth quarter 2015 financial results conference call and live webcast on &lt;/div&gt;</description>
         <guid isPermaLink="false"></guid>
         <pubDate>Thu, 01 Oct 2015 00:00:00 +0000</pubDate>
      </item>
      <item>
         <title>Carestream Health Release: New Imaging Technology At Conference</title>
         <link>http://www.biospace.com/news_story.aspx?StoryID=393483&amp;full=1</link>
         <description>Carestream Spotlights New CBCT Research, DR Systems for Orthopaedic and Sports Medicine Care Providers&lt;br&gt;&lt;br&gt;SAN DIEGO, Sept. 30  At the upcoming Orthopaedic Trauma Association conference that begins Oct. 7, Carestream is showcasing new products, software and technology in development that can address the demanding needs of orthopaedic and sports medicine care providers.&lt;br&gt;&lt;br&gt;Carestream...</description>
         <guid isPermaLink="false"></guid>
         <pubDate>Thu, 01 Oct 2015 00:00:00 +0000</pubDate>
      </item>
      <item>
         <title>New Salk-Helmsley Fellow brings cutting-edge gene editing technologies to the Salk Institute</title>
         <link>http://www.salk.edu/news/pressrelease_details.php?press_id=2117</link>
         <description>&lt;p&gt;
LA JOLLA&amp;mdash;The Salk Institute is pleased to announce the appointment of bioengineer Patrick Hsu in the innovative &lt;a rel=&quot;nofollow&quot; target=&quot;_blank&quot; href=&quot;http://www.salk.edu/careers/fellows_program.html&quot;&gt;Salk Fellows Program&lt;/a&gt;. Hsu, who hails from Harvard University and MIT&amp;rsquo;s Broad Institute, aims to develop the next generation of medical therapeutics by harnessing the gene editing technology known as CRISPR. A gene editing technique originally derived from bacterial immune systems, CRISPR has recently made headlines for its use in modifying DNA with unprecedented ease and accuracy.</description>
         <guid isPermaLink="false">http://www.salk.edu/news/pressrelease_details.php?press_id=2117</guid>
         <pubDate>Thu, 01 Oct 2015 00:00:00 +0000</pubDate>
      </item>
      <item>
         <title>Viral revival may cause ALS</title>
         <link>http://www.sandiegouniontribune.com/news/2015/sep/30/als-endogenous-retrovirus/</link>
         <description>Human retrovirus HERV-K damages motor neurons of some ALS patients, study finds.</description>
         <guid isPermaLink="false">http://www.sandiegouniontribune.com/news/2015/sep/30/als-endogenous-retrovirus/</guid>
         <pubDate>Wed, 30 Sep 2015 18:00:00 +0000</pubDate>
      </item>
      <item>
         <title>Mentors and Postdocs Earn Chancellor’s ‘Postdoc Appreciation’ Awards for Guidance, Research</title>
         <link>http://ucsdnews.ucsd.edu/pressrelease/mentors_and_postdocs_earn_chancellors_postdoc_appreciation_awards_for_guida</link>
         <description>&lt;p&gt;&lt;img style=&quot;float:left;margin:0 20px 10px 0;&quot; src=&quot;http://ucsdnews.ucsd.edu/news_uploads/Postdoc-Awards-150930-t.jpg&quot;/&gt;&lt;/p&gt;
      								&lt;p&gt;Those who attended this year’s recent Postdoc Research Symposium and Postdoc Appreciation Lunch and Awards Ceremony sampled research projects from 25 different departments, and desert at the crowded Appreciation Lunch took the form of well-deserved awards.</description>
         <guid isPermaLink="false">http://ucsdnews.ucsd.edu/pressrelease/mentors_and_postdocs_earn_chancellors_postdoc_appreciation_awards_for_guida#When:17:01:00Z</guid>
         <pubDate>Wed, 30 Sep 2015 17:01:00 +0000</pubDate>
         <enclosure type="image/jpeg" url="http://ucsdnews.ucsd.edu/news_uploads/Postdoc-Awards-150930-t.jpg"/>
      </item>
      <item>
         <title>UC San Diego Health Joins Leading National Network Targeting Depressive Illnesses</title>
         <link>http://ucsdnews.ucsd.edu/pressrelease/uc_san_diego_health_joins_leading_national_network_targeting_depressive_ill</link>
         <description>&lt;p&gt;UC San Diego Health has been designated a member of the National Network of Depression Centers (NNDC), a consortium of leading academic medical centers working to accelerate research, education and improved treatment options for people with depressive and bipolar illnesses. UC San Diego Health joins 22 other institutions in the nationwide nonprofit network.</description>
         <guid isPermaLink="false">http://ucsdnews.ucsd.edu/pressrelease/uc_san_diego_health_joins_leading_national_network_targeting_depressive_ill#When:16:30:00Z</guid>
         <pubDate>Wed, 30 Sep 2015 16:30:00 +0000</pubDate>
      </item>
      <item>
         <title>Lpath Appoints Interim CEO</title>
         <link>http://www.biospace.com/news_story.aspx?StoryID=393160&amp;full=1</link>
         <description>&lt;div&gt;&lt;p&gt;&lt;span&gt;SAN DIEGO&lt;/span&gt;, &lt;span&gt;Sept. 29, 2015&lt;/span&gt; /PRNewswire/ -- Lpath, Inc. (NASDAQ: LPTN), the industry leader in bioactive lipid-targeted therapeutics, announced that &lt;span&gt;Gary Atkinson&lt;/span&gt; has been appointed interim chief executive officer of Lpath, effective immediately. Mr. Atkinson will continue to serve...&lt;/div&gt;</description>
         <guid isPermaLink="false"></guid>
         <pubDate>Wed, 30 Sep 2015 00:00:00 +0000</pubDate>
      </item>
      <item>
         <title>Zogenix Reports Positive Top-Line Results From Relday Phase Ib Multi-Dose Clinical Trial</title>
         <link>http://www.biospace.com/news_story.aspx?StoryID=393201&amp;full=1</link>
         <description>&lt;p&gt;&lt;i&gt;Product Candidate Now Phase 3 Ready&lt;/i&gt; &lt;/p&gt; &lt;p&gt; &lt;i&gt;Company Initiates Efforts to Secure Global Development and Commercialization Partner&lt;/i&gt; &lt;/p&gt; &lt;p&gt; SAN DIEGO, Sept. 30, 2015 (GLOBE NEWSWIRE) -- Zogenix, Inc. (Nasdaq:ZGNX), a pharmaceutical company developing therapies...</description>
         <guid isPermaLink="false"></guid>
         <pubDate>Wed, 30 Sep 2015 00:00:00 +0000</pubDate>
      </item>
      <item>
         <title>Neothetics Initiates Study To Evaluate The Safety Of LIPO-202 For Body Contouring In Obese Subjects</title>
         <link>http://www.biospace.com/news_story.aspx?StoryID=393222&amp;full=1</link>
         <description>&lt;p&gt;SAN DIEGO, Sept. 30, 2015 (GLOBE NEWSWIRE) -- Neothetics, Inc. (NASDAQ:NEOT), a clinical-stage specialty pharmaceutical company developing therapeutics for the aesthetic market, today announced the initiation of the safety study, LIPO-202-CL-21, of LIPO-202, the first non-invasive injectable drug candidate...</description>
         <guid isPermaLink="false"></guid>
         <pubDate>Wed, 30 Sep 2015 00:00:00 +0000</pubDate>
      </item>
      <item>
         <title>Kura Oncology Initiates Phase II Study Of Tipifarnib In Peripheral T-Cell Lymphoma</title>
         <link>http://www.biospace.com/news_story.aspx?StoryID=393220&amp;full=1</link>
         <description>&lt;p&gt;LA JOLLA, Calif., Sept. 30, 2015 (GLOBE NEWSWIRE) -- Kura Oncology, Inc. (OTCQB:KURO), a clinical stage biopharmaceutical company advancing a pipeline of precision medicines for the treatment of solid tumors and blood cancers, today announced it has initiated a Phase 2 clinical trial of tipifarnib in...</description>
         <guid isPermaLink="false"></guid>
         <pubDate>Wed, 30 Sep 2015 00:00:00 +0000</pubDate>
      </item>
      <item>
         <title>Mast Therapeutics Announces Amendment To Loan And Security Agreement With</title>
         <link>http://www.biospace.com/news_story.aspx?StoryID=393168&amp;full=1</link>
         <description>&lt;div&gt;&lt;p&gt;&lt;span&gt;SAN DIEGO&lt;/span&gt;, &lt;span&gt;Sept. 30, 2015&lt;/span&gt; /PRNewswire/ -- &lt;a rel=&quot;nofollow&quot;&gt;Mast Therapeutics, Inc.&lt;/a&gt; (NYSE MKT: MSTX), a clinical-stage biopharmaceutical company leveraging its molecular adhesion and sealant technology (MAST) platform to develop novel therapies for sickle...&lt;/div&gt;</description>
         <guid isPermaLink="false"></guid>
         <pubDate>Wed, 30 Sep 2015 00:00:00 +0000</pubDate>
      </item>
      <item>
         <title>MabVax Therapeutics Holdings, Inc. Announces Pricing Of Public Offering</title>
         <link>http://www.biospace.com/news_story.aspx?StoryID=393253&amp;full=1</link>
         <description>&lt;div&gt;&lt;p&gt;&lt;span&gt;SAN DIEGO&lt;/span&gt;, &lt;span&gt;Sept. 30, 2015&lt;/span&gt; /PRNewswire/ --MabVax Therapeutics Holdings, Inc. (OTCQB: MBVX) (&quot;MabVax&quot;), a clinical-stage immuno-oncology drug development company, today announced the pricing of its public offering of 2,500,000 shares of its common stock at an offering price to the public of &lt;/div&gt;</description>
         <guid isPermaLink="false"></guid>
         <pubDate>Wed, 30 Sep 2015 00:00:00 +0000</pubDate>
      </item>
      <item>
         <title>Edico Genome Release: Study: Whole-Genome Sequencing Technology Enables 26-Hour Diagnosis Of Critically Ill Newborns, Nearly Halving Previous Record For Speed</title>
         <link>http://www.biospace.com/news_story.aspx?StoryID=393184&amp;full=1</link>
         <description>&lt;div&gt;&lt;p /&gt;&lt;p /&gt;&lt;p&gt;&lt;span&gt;KANSAS CITY, Mo.&lt;/span&gt; and &lt;span&gt;SAN DIEGO&lt;/span&gt;, &lt;span&gt;Sept. 29, 2015&lt;/span&gt; /PRNewswire/ --Rapid diagnosis is essential in acute care situations, particularly in neonatal intensive care units where medical decision-making must happen in minutes and hours, not weeks. Today, Children's Mercy Kansas...&lt;/div&gt;</description>
         <guid isPermaLink="false"></guid>
         <pubDate>Wed, 30 Sep 2015 00:00:00 +0000</pubDate>
      </item>
      <item>
         <title>Otonomy To Host Investor And Analyst Day On October 7, 2015</title>
         <link>http://www.biospace.com/news_story.aspx?StoryID=393258&amp;full=1</link>
         <description>&lt;p&gt;SAN DIEGO, Sept. 30, 2015 (GLOBE NEWSWIRE) -- Otonomy, Inc. (Nasdaq:OTIC) will host an Investor and Analyst Day on Wednesday, October 7, 2015, from 8:30 a.m. to 11:30 a.m. EDT (5:30 a.m. to 8:30 a.m. PDT) in New York City. David A. Weber, Ph.D., president and chief executive officer, and other members...</description>
         <guid isPermaLink="false"></guid>
         <pubDate>Wed, 30 Sep 2015 00:00:00 +0000</pubDate>
      </item>
      <item>
         <title>University of California, San Francisco (UCSF) Orthopaedic Institute Finds Disposable, Plastic Spine Instrument By Outperforms Metal Counterpart</title>
         <link>http://www.biospace.com/news_story.aspx?StoryID=393303&amp;full=1</link>
         <description>&lt;div&gt;&lt;p&gt;SAN DIEGO--(&lt;a rel=&quot;nofollow&quot;&gt;BUSINESS WIRE&lt;/a&gt;)--The &lt;a rel=&quot;nofollow&quot;&gt;UCSF&lt;/a&gt;       Orthopaedic Trauma Institute...&lt;/div&gt;</description>
         <guid isPermaLink="false"></guid>
         <pubDate>Wed, 30 Sep 2015 00:00:00 +0000</pubDate>
      </item>
      <item>
         <title>Uncovering the Secrets of the Adolescent Brain</title>
         <link>http://ucsdnews.ucsd.edu/pressrelease/uncovering_the_secrets_of_the_adolescent_brain</link>
         <description>&lt;p&gt;&lt;img style=&quot;float:left;margin:0 20px 10px 0;&quot; src=&quot;http://ucsdnews.ucsd.edu/news_uploads/adolescent-brain-150929-t.jpg&quot;/&gt;&lt;/p&gt;
      								&lt;p&gt;A cross-disciplinary team of University of California, San Diego social and medical scientists will lead an ambitious, longitudinal national study to probe the mysteries of the adolescent brain.</description>
         <guid isPermaLink="false">http://ucsdnews.ucsd.edu/pressrelease/uncovering_the_secrets_of_the_adolescent_brain#When:19:41:00Z</guid>
         <pubDate>Tue, 29 Sep 2015 19:41:00 +0000</pubDate>
         <enclosure type="image/jpeg" url="http://ucsdnews.ucsd.edu/news_uploads/adolescent-brain-150929-t.jpg"/>
      </item>
      <item>
         <title>“Top Docs” Continue to Raise the Bar at UC San Diego Health</title>
         <link>http://ucsdnews.ucsd.edu/pressrelease/top_docs_continue_to_raise_the_bar_at_uc_san_diego_health</link>
         <description>&lt;p&gt;The votes are in and more than 100 physicians from UC San Diego Health were named “Top Docs” in the annual &lt;em&gt;San Diego Magazine&lt;/em&gt; “Physicians of Exceptional Excellence” annual survey. These physicians represent 41 diverse specialties, from family medicine, surgery and oncology to obstetrics, cardiology and emergency medicine.</description>
         <guid isPermaLink="false">http://ucsdnews.ucsd.edu/pressrelease/top_docs_continue_to_raise_the_bar_at_uc_san_diego_health#When:15:44:00Z</guid>
         <pubDate>Tue, 29 Sep 2015 15:44:00 +0000</pubDate>
      </item>
      <item>
         <title>My Déjà vu Moment in Genomics: Why We Need Industry Standards Now</title>
         <link>http://feedproxy.google.com/~r/Xconomy_San_Diego_Life_Sciences/~3/deEfgZh57Fo/</link>
         <guid isPermaLink="false">http://www.xconomy.com/?p=309468</guid>
         <pubDate>Tue, 29 Sep 2015 09:40:18 +0000</pubDate>
         <content:encoded><![CDATA[I am a serial entrepreneur who has spent the past couple of decades advancing the front lines of technology in digital healthcare, wireless communications, and semiconductor industries. And I’ve been...<br/>
<br/>
[[Click headline to continue reading.]]<img src="http://feeds.feedburner.com/~r/Xconomy_San_Diego_Life_Sciences/~4/deEfgZh57Fo" height="1" width="1" alt=""/>]]></content:encoded>
      </item>
      <item>
         <title>Dunsire, Forum Search For Answers After FDA Halts Alzheimer’s Trial</title>
         <link>http://feedproxy.google.com/~r/Xconomy_San_Diego_Life_Sciences/~3/PFDWRlR8hEc/</link>
         <guid isPermaLink="false">http://www.xconomy.com/?p=309920</guid>
         <pubDate>Tue, 29 Sep 2015 07:00:09 +0000</pubDate>
         <content:encoded><![CDATA[A litany of promising therapies for Alzheimer’s disease have crashed and burned in late-stage testing. So it was an ominous sign when the FDA recently placed a clinical hold on a big Phase 3 trial...<br/>
<br/>
[[Click headline to continue reading.]]<img src="http://feeds.feedburner.com/~r/Xconomy_San_Diego_Life_Sciences/~4/PFDWRlR8hEc" height="1" width="1" alt=""/>]]></content:encoded>
      </item>
      <item>
         <title>HedgePath Pharmaceuticals Announces Commencement Of Patient Treatment In Its Phase II(b) Clinical Trial</title>
         <link>http://www.biospace.com/news_story.aspx?StoryID=392935&amp;full=1</link>
         <description>&lt;div&gt;&lt;p&gt;&lt;span&gt;TAMPA, Fla.&lt;/span&gt; and &lt;span&gt;SAN DIEGO&lt;/span&gt;, &lt;span&gt;Sept. 29, 2015&lt;/span&gt; /PRNewswire/ --HedgePath Pharmaceuticals, Inc. (OTCQB:HPPI), a clinical stage biopharmaceutical company that discovers, develops and plans to commercialize innovative therapeutics for patients with cancer, announced today that initial...&lt;/div&gt;</description>
         <guid isPermaLink="false"></guid>
         <pubDate>Tue, 29 Sep 2015 00:00:00 +0000</pubDate>
      </item>
      <item>
         <title>Regen BioPharma  Cancer Stem Cell Gene Target Shown to be a Key Mediator of Cancer Immune Surveillance by Independent Researchers</title>
         <link>http://www.biospace.com/news_story.aspx?StoryID=393025&amp;full=1</link>
         <description>SAN DIEGO, September 29, 2015 /PRNewswire/ --&lt;br&gt;&lt;br&gt;Regen BioPharma Inc. (OTCBB: RGBP) and (PINK: RGBP) reported today that an independent research laboratory has published that the cancer stem cell target gene NR2F6 is a key gene that controls anti-tumor immune surveillance. Regen BioPharma has several pieces of intellectual property related to NR2F6 including issued United States patent # ...</description>
         <guid isPermaLink="false"></guid>
         <pubDate>Tue, 29 Sep 2015 00:00:00 +0000</pubDate>
      </item>
      <item>
         <title>Ligand Expands Captisol License And Supply Agreements With SAGE Therapeutics To Include SAGE-689</title>
         <link>http://www.biospace.com/news_story.aspx?StoryID=393051&amp;full=1</link>
         <description>&lt;div&gt;&lt;p&gt;SAN DIEGO--(&lt;a rel=&quot;nofollow&quot;&gt;BUSINESS WIRE&lt;/a&gt;)--&lt;b&gt;Ligand Pharmaceuticals Incorporated (NASDAQ: LGND) &lt;/b&gt;announces it       has expanded its global license and supply agreements with SAGE       Therapeutics (SAGE) to now also cover the use of Captisol in the       development and commercialization of SAGE-689. Under the terms of the       license...&lt;/div&gt;</description>
         <guid isPermaLink="false"></guid>
         <pubDate>Tue, 29 Sep 2015 00:00:00 +0000</pubDate>
      </item>
      <item>
         <title>Amydis Diagnostics Awarded NIA-NIH Grant To Investigate Innovative Technology For Detection Of Alzheimer's Disease</title>
         <link>http://www.biospace.com/news_story.aspx?StoryID=392991&amp;full=1</link>
         <description>&lt;p&gt;SAN DIEGO, Sept. 29, 2015 (GLOBE NEWSWIRE) -- Amydis Diagnostics, Inc., a preclinical stage, privately-held pharmaceutical company developing proprietary chemistry and innovative approaches to detection of amyloidgenic protein-associated diseases, today announced a grant award by the National Institute...</description>
         <guid isPermaLink="false"></guid>
         <pubDate>Tue, 29 Sep 2015 00:00:00 +0000</pubDate>
      </item>
      <item>
         <title>Therapeutic Solutions International Files Patent On Immune Therapy Medical Device To Prevent Preterm Labor</title>
         <link>http://www.biospace.com/news_story.aspx?StoryID=393112&amp;full=1</link>
         <description>&lt;div&gt;&lt;p&gt;OCEANSIDE, CA--(Marketwired - September 29, 2015) -   Therapeutics Solutions International, Inc., (OTC PINK: &lt;a rel=&quot;nofollow&quot;&gt;TSOI&lt;/a&gt;) announces the filing of U.S. Patent No. 62/232722 titled &quot;A Medical Device For Reducing The Risk Of Preterm-Labor And Preterm-Birth,&quot; covering various medical devices aimed at immune modulating the...&lt;/div&gt;</description>
         <guid isPermaLink="false"></guid>
         <pubDate>Tue, 29 Sep 2015 00:00:00 +0000</pubDate>
      </item>
      <item>
         <title>Illumina Launches TruSight Tumor OncoPanel</title>
         <link>http://www.businesswire.com/portal/site/biospace/index.jsp?ndmViewId=news_view&amp;newsId=20150929005580&amp;newsLang=en</link>
         <description>SAN DIEGO--(BUSINESS WIRE)--Illumina, Inc. (NASDAQ:ILMN) today announced it has launched TruSight Tumor 15, a next-generation sequencing (NGS) panel designed to identify sequence variants in 15 genes commonly associated with marketed therapeutics. TruSight Tumor 15 is optimized for low input DNA from tissue preserved in formalin and paraffin.&lt;br&gt;&lt;br&gt;Help employers find you! Check out all the</description>
         <guid isPermaLink="false"></guid>
         <pubDate>Tue, 29 Sep 2015 00:00:00 +0000</pubDate>
      </item>
      <item>
         <title>Aethlon Medical Extends Contract With The</title>
         <link>http://www.biospace.com/news_story.aspx?StoryID=392952&amp;full=1</link>
         <description>&lt;div&gt;&lt;p&gt;&lt;span&gt;SAN DIEGO&lt;/span&gt;, &lt;span&gt;Sept. 28, 2015&lt;/span&gt; /PRNewswire/ --Aethlon Medical, Inc. (Nasdaq: AEMD), today announced that it has entered into an extension of its contract with the Defense Advanced Research Projects Agency, or DARPA, part of the Department of Defense. The Company originally entered into the initial DARPA contract on...&lt;/div&gt;</description>
         <guid isPermaLink="false"></guid>
         <pubDate>Tue, 29 Sep 2015 00:00:00 +0000</pubDate>
      </item>
      <item>
         <title>NCI Renews Funding for San Diego Universities, Community Health Centers to Work Together</title>
         <link>http://ucsdnews.ucsd.edu/pressrelease/nci_renews_funding_for_san_diego_universities_community_health_centers_to_w</link>
         <description>&lt;p&gt;A collaborative program aimed at reducing the burden of cancer among Hispanic/Latinos in San Diego and Imperial counties through research and community outreach has received a $13 million grant from the National Cancer Institute (NCI), part of the National Institutes of Health. The five-year grant renews funding for a partnership started in 2008 between San Diego State University and Moores Cancer Center at UC San Diego Health.</description>
         <guid isPermaLink="false">http://ucsdnews.ucsd.edu/pressrelease/nci_renews_funding_for_san_diego_universities_community_health_centers_to_w#When:17:27:00Z</guid>
         <pubDate>Mon, 28 Sep 2015 17:27:00 +0000</pubDate>
      </item>
      <item>
         <title>SDSC Upgrades Cloud Computing Storage Services</title>
         <link>http://ucsdnews.ucsd.edu/pressrelease/sdsc_upgrades_cloud_computing_storage_services</link>
         <description>&lt;p&gt;&lt;img style=&quot;float:left;margin:0 20px 10px 0;&quot; src=&quot;http://ucsdnews.ucsd.edu/news_uploads/Cloud-Compute-visual-150928-t.jpg&quot;/&gt;&lt;/p&gt;
      								&lt;p&gt;The San Diego Supercomputer Center (SDSC) at the University of California, San Diego, has made significant upgrades to its cloud-based storage system to include a new range of computing services designed to support science-based researchers, especially those with large data requirements that preclude commercial cloud use, or who require collaboration with cloud engineers for building cloud-based services.</description>
         <guid isPermaLink="false">http://ucsdnews.ucsd.edu/pressrelease/sdsc_upgrades_cloud_computing_storage_services#When:16:41:00Z</guid>
         <pubDate>Mon, 28 Sep 2015 16:41:00 +0000</pubDate>
         <enclosure type="image/jpeg" url="http://ucsdnews.ucsd.edu/news_uploads/Cloud-Compute-visual-150928-t.jpg"/>
      </item>
      <item>
         <title>Scientists Identify a Key Morphine Regulator that May Reduce Risk of Pain-Killer Abuse and Addiction</title>
         <link>http://www.scripps.edu/newsandviews/e_20150928/martemyanov.html</link>
         <description>The findings could lead to a new drug target for developing less-addictive pain medications.</description>
         <guid isPermaLink="false">http://www.scripps.edu /newsandviews/e_20150928/martemyanov.html</guid>
         <pubDate>Mon, 28 Sep 2015 07:00:00 +0000</pubDate>
      </item>
      <item>
         <title>Study Identifies Novel Role of Mitochondria in Immune Function</title>
         <link>http://www.scripps.edu/newsandviews/e_20150928/kang.html</link>
         <description>The research from the Kang and Lerner labs reveals new targets for treating cancer and autoimmune diseases.</description>
         <guid isPermaLink="false">http://www.scripps.edu /newsandviews/e_20150928/kang.html</guid>
         <pubDate>Mon, 28 Sep 2015 07:00:00 +0000</pubDate>
      </item>
      <item>
         <title>Researchers Awarded $6 Million to Develop Alternative HIV/AIDS Vaccine</title>
         <link>http://www.scripps.edu/newsandviews/e_20150928/farzan.html</link>
         <description>“I’m grateful to the Gates Foundation for its strong support of our research and for its continued commitment to eradicating HIV/AIDS throughout the world,” says Professor Michael Farzan.</description>
         <guid isPermaLink="false">http://www.scripps.edu /newsandviews/e_20150928/farzan.html</guid>
         <pubDate>Mon, 28 Sep 2015 07:00:00 +0000</pubDate>
      </item>
      <item>
         <title>James Williamson Named VP for Academic Affairs; Douglas Bingham Appointed Executive VP/COO</title>
         <link>http://www.scripps.edu/newsandviews/e_20150928/appointments.html</link>
         <description>“I look forward to capitalizing on [Jamie and Doug’s] extensive experience to help realize our exciting vision for TSRI's future,” says President-Elect Steve Kay.</description>
         <guid isPermaLink="false">http://www.scripps.edu /newsandviews/e_20150928/appointments.html</guid>
         <pubDate>Mon, 28 Sep 2015 07:00:00 +0000</pubDate>
      </item>
      <item>
         <title>Sorrento Inks $170 Million Exclusive Deal With City of Hope</title>
         <link>http://www.biospace.com/news_story.aspx?StoryID=392759&amp;full=1</link>
         <description>&lt;font&gt;&lt;b&gt;Sorrento Therapeutics And City Of Hope Announce Exclusive License To Develop First-In-Class Immunotherapies Against Intracellular Targets&lt;/font&gt;&lt;/b&gt;&lt;br&gt;&lt;div&gt;&lt;p&gt;&lt;span&gt;SAN DIEGO&lt;/span&gt; and &lt;span&gt;DUARTE, Calif.&lt;/span&gt;, &lt;span&gt;Sept. 28, 2015&lt;/span&gt; /PRNewswire/ --&lt;/div&gt;</description>
         <guid isPermaLink="false"></guid>
         <pubDate>Mon, 28 Sep 2015 00:00:00 +0000</pubDate>
      </item>
      <item>
         <title>OncoSec Medical Inc. Announces Positive Results From Phase II Trial Of ImmunoPulse IL-12 In Merkel Cell Carcinoma</title>
         <link>http://www.biospace.com/news_story.aspx?StoryID=392685&amp;full=1</link>
         <description>&lt;div&gt;&lt;p&gt;&lt;span&gt;SAN DIEGO&lt;/span&gt;, &lt;span&gt;Sept. 27, 2015&lt;/span&gt; /PRNewswire/ -- OncoSec Medical Incorporated (&quot;OncoSec&quot;) (NASDAQ: ONCS), a company developing DNA-based intratumoral cancer immunotherapies, today announced results from a Phase II trial demonstrating that its investigational therapy, ImmunoPulse IL-12, promotes tumor-specific, systemic...&lt;/div&gt;</description>
         <guid isPermaLink="false"></guid>
         <pubDate>Mon, 28 Sep 2015 00:00:00 +0000</pubDate>
      </item>
      <item>
         <title>Ansun BioPharma Announces CDC Publication Showing Potent Inhibitory Effects Of DAS181 On Enterovirus68</title>
         <link>http://www.biospace.com/news_story.aspx?StoryID=392720&amp;full=1</link>
         <description>&lt;div&gt;&lt;p&gt;&lt;span&gt;SAN DIEGO&lt;/span&gt;, &lt;span&gt;Sept. 28, 2015&lt;/span&gt; /PRNewswire/ --Ansun BioPharma announced today the publication of a report by researchers at the Centers for Disease Control demonstrating the strong inhibition of Enterovirus68 (EV68) by DAS181. The report published in the peer reviewed journal, Antimicrobial Agents and Chemotherapy...&lt;/div&gt;</description>
         <guid isPermaLink="false"></guid>
         <pubDate>Mon, 28 Sep 2015 00:00:00 +0000</pubDate>
      </item>
      <item>
         <title>Regen BioPharma  Announces Positive Results From GLP Safety Study For HemaXellerate</title>
         <link>http://www.biospace.com/news_story.aspx?StoryID=392688&amp;full=1</link>
         <description>SAN DIEGO, September 25, 2015 /PRNewswire/ -- &lt;br&gt;&lt;br&gt;Final Experiments Requested by FDA Completed &lt;br&gt;&lt;br&gt;Regen BioPharma Inc. (OTCBB: RGBP) and (OTC PINK: RGBP) announced today receipt of the audited draft report from contract research organization Charles River, describing positive conclusions derived from animal safety studies requested by the FDA regarding Regen's Investigational New...</description>
         <guid isPermaLink="false"></guid>
         <pubDate>Mon, 28 Sep 2015 00:00:00 +0000</pubDate>
      </item>
      <item>
         <title>Triphase Accelerator Announces Phase 1 Study Results With Marizomib In Combination With Pomalidomide And Dexamethasone In Patients With Relapsed And Refractory Multiple Myeloma</title>
         <link>http://www.biospace.com/news_story.aspx?StoryID=392901&amp;full=1</link>
         <description>&lt;div&gt;&lt;p&gt;TORONTO &amp; SAN DIEGO--(&lt;a rel=&quot;nofollow&quot;&gt;BUSINESS WIRE&lt;/a&gt;)--Triphase Accelerator Corporation, a private drug development company       dedicated to advancing novel compounds through Phase 2 proof-of-concept,       today announced preliminary results of a Phase 1 dose-escalation study       of marizomib in combination with pomalidomide (POM) and low...&lt;/div&gt;</description>
         <guid isPermaLink="false"></guid>
         <pubDate>Mon, 28 Sep 2015 00:00:00 +0000</pubDate>
      </item>
      <item>
         <title>Ignyta Announces Updated Interim Data From Entrectinib Phase 1 Clinical Trials At The 2015</title>
         <link>http://www.biospace.com/news_story.aspx?StoryID=392894&amp;full=1</link>
         <description>&lt;div&gt;&lt;p&gt;SAN DIEGO--(&lt;a rel=&quot;nofollow&quot;&gt;BUSINESS WIRE&lt;/a&gt;)--Ignyta, Inc. (Nasdaq: RXDX),&lt;b&gt; &lt;/b&gt;a precision oncology       biotechnology company, today announced that updated interim results of       its Phase 1 clinical trials of entrectinib, the company's proprietary       oral tyrosine kinase inhibitor targeting solid tumors that harbor       activating...&lt;/div&gt;</description>
         <guid isPermaLink="false"></guid>
         <pubDate>Mon, 28 Sep 2015 00:00:00 +0000</pubDate>
      </item>
      <item>
         <title>Vital Therapies Outlines Plans For New Phase 3 Trial Of ELAD In Alcohol-Induced Liver Decompensation</title>
         <link>http://www.biospace.com/news_story.aspx?StoryID=392703&amp;full=1</link>
         <description>&lt;p&gt;SAN DIEGO, Sept. 28, 2015 (GLOBE NEWSWIRE) -- Vital Therapies, Inc. (Nasdaq:VTL), a biotherapeutic company developing ELAD, a cell-based therapy targeting the treatment of liver failure, today outlined plans for a possible new phase 3 clinical trial designed to confirm ELAD's safety and efficacy in...</description>
         <guid isPermaLink="false"></guid>
         <pubDate>Mon, 28 Sep 2015 00:00:00 +0000</pubDate>
      </item>
      <item>
         <title>Biocept, Inc. Announces Participation In s Networks</title>
         <link>http://www.businesswire.com/portal/site/biospace/template.PAGE/menuitem.ab520ce17e34ab71ff00d635c0908a0c/index.jsp?ndmViewId=news_view&amp;newsId=20150928005309&amp;newsLang=en</link>
         <description>SAN DIEGO--(BUSINESS WIRE)--Biocept, Inc. (NASDAQ: BIOC), a molecular diagnostics company commercializing and developing liquid biopsies to improve the detection and treatment of cancer, announces that it has entered into an agreement with MultiPlan, Inc. for participation in its national primary PPO, the PHCS Network, and its complementary network, the MultiPlan Network, effective August 1, 2015...</description>
         <guid isPermaLink="false"></guid>
         <pubDate>Mon, 28 Sep 2015 00:00:00 +0000</pubDate>
      </item>
      <item>
         <title>Human Longevity Inc. Appoints As Chief Financial Officer</title>
         <link>http://www.biospace.com/news_story.aspx?StoryID=392767&amp;full=1</link>
         <description>&lt;div&gt;&lt;p&gt;&lt;span&gt;SAN DIEGO&lt;/span&gt;, &lt;span&gt;Sept. 28, 2015&lt;/span&gt; /PRNewswire/ -- Human Longevity, Inc. (HLI), the genomics-based, technology-driven company, announced today that &lt;span&gt;William A. Roper, Jr.&lt;/span&gt; has been appointed Chief Financial Officer, reporting directly to HLI's CEO, &lt;span&gt;J. Craig Venter&amp;lt;...&lt;/span&gt;&lt;/div&gt;</description>
         <guid isPermaLink="false"></guid>
         <pubDate>Mon, 28 Sep 2015 00:00:00 +0000</pubDate>
      </item>
      <item>
         <title>Neothetics Expands Its Board Of Directors With Appointments Of And</title>
         <link>http://www.biospace.com/news_story.aspx?StoryID=392790&amp;full=1</link>
         <description>&lt;p&gt;SAN DIEGO, Sept. 28, 2015 (GLOBE NEWSWIRE) -- Neothetics, Inc. (NASDAQ:NEOT) today announced that it has named Jeffrey Nugent and Hani Zeini to its Board of Directors.&lt;/p&gt; &lt;p&gt; Mr. Nugent is a respected business leader who brings a broad range of valuable experiences to Neothetics. He has over 25 years...</description>
         <guid isPermaLink="false"></guid>
         <pubDate>Mon, 28 Sep 2015 00:00:00 +0000</pubDate>
      </item>
      <item>
         <title>Regen BioPharma  Director Of Molecular Therapeutics To Speak At Stem Cell Conference Regarding Leukemia Research Being Conducted By The Company</title>
         <link>http://www.biospace.com/news_story.aspx?StoryID=392870&amp;full=1</link>
         <description>SAN DIEGO, September 28, 2015 /PRNewswire/ --&lt;br&gt;&lt;br&gt;Dr. Christine Ichim will present at Stem Cell Meeting on the Mesa &lt;br&gt;&lt;br&gt;Regen BioPharma, Inc., (OTCBB: RGBP) and (PINK: RGBP) announced today that Dr. Christine Ichim, Director of Molecular Therapeutics at Regen, was selected by the organizers of Stem Cell Meeting on the Mesa to speak at the conference regarding ongoing leukemia research...</description>
         <guid isPermaLink="false"></guid>
         <pubDate>Mon, 28 Sep 2015 00:00:00 +0000</pubDate>
      </item>
      <item>
         <title>GenomeDx Biosciences Secures Financing From</title>
         <link>http://www.biospace.com/news_story.aspx?StoryID=392730&amp;full=1</link>
         <description>&lt;div&gt;&lt;p&gt;&lt;span&gt;SAN DIEGO&lt;/span&gt;, &lt;span&gt;Sept. 28, 2015&lt;/span&gt; /PRNewswire/ --GenomeDx Biosciences announced today that it has secured expansion financing from CRG, a premier healthcare investment firm, in the form of a senior secured term loan. &lt;/p&gt;&lt;p&gt;&quot;We are pleased to have the support of CRG, an investment partner renowned for its strategic investments...&lt;/div&gt;</description>
         <guid isPermaLink="false"></guid>
         <pubDate>Mon, 28 Sep 2015 00:00:00 +0000</pubDate>
      </item>
      <item>
         <title>Sequenom Updates Second Half 2015 Revenue Outlook</title>
         <link>http://www.biospace.com/news_story.aspx?StoryID=392778&amp;full=1</link>
         <description>&lt;div&gt;&lt;p&gt;&lt;span&gt;SAN DIEGO&lt;/span&gt;, &lt;span&gt;Sept. 25, 2015&lt;/span&gt; /PRNewswire/ -- Sequenom, Inc. (NASDAQ: SQNM), a life sciences company committed to enabling healthier lives through the development of innovative products and services, provides its current revenue outlook for the second half of 2015.&lt;/p&gt;&lt;p&gt;The Company is updating its revenue expectations...&lt;/div&gt;</description>
         <guid isPermaLink="false"></guid>
         <pubDate>Mon, 28 Sep 2015 00:00:00 +0000</pubDate>
      </item>
      <item>
         <title>Author: Your smartphone will become your physician</title>
         <link>http://www.sandiegouniontribune.com/news/2015/sep/27/robin-cook-idoc/</link>
         <description>Author-futurist Robin Cook discusses the coming of iDoc.</description>
         <guid isPermaLink="false">http://www.sandiegouniontribune.com/news/2015/sep/27/robin-cook-idoc/</guid>
         <pubDate>Sun, 27 Sep 2015 20:30:45 +0000</pubDate>
      </item>
      <item>
         <title>SD science calendar: Nobels, stem cells and robots</title>
         <link>http://www.sandiegouniontribune.com/news/2015/sep/26/nobels-stell-cells/</link>
         <description>There ill</description>
         <guid isPermaLink="false">http://www.sandiegouniontribune.com/news/2015/sep/26/nobels-stell-cells/</guid>
         <pubDate>Sun, 27 Sep 2015 01:59:59 +0000</pubDate>
      </item>
      <item>
         <title>Oddsmakers ignore San Diego in upcoming Nobels</title>
         <link>http://www.sandiegouniontribune.com/news/2015/sep/26/nobel-prize-announcement/</link>
         <description>But Thomson Reuters like a Californian</description>
         <guid isPermaLink="false">http://www.sandiegouniontribune.com/news/2015/sep/26/nobel-prize-announcement/</guid>
         <pubDate>Sun, 27 Sep 2015 00:17:20 +0000</pubDate>
      </item>
      <item>
         <title>West Coast Biotech Roundup: Gilead, Conatus, Exelixis, and More</title>
         <link>http://feedproxy.google.com/~r/Xconomy_San_Diego_Life_Sciences/~3/s-cR0ZhnefQ/</link>
         <guid isPermaLink="false">http://www.xconomy.com/?p=309753</guid>
         <pubDate>Fri, 25 Sep 2015 14:54:31 +0000</pubDate>
         <content:encoded><![CDATA[Those of you who thought that DreamWorks’ Shrek franchise ended in 2010 with Shrek Ever After may have been surprised when a new installment played out over the past week with the big green ogre...<br/>
<br/>
[[Click headline to continue reading.]]<img src="http://feeds.feedburner.com/~r/Xconomy_San_Diego_Life_Sciences/~4/s-cR0ZhnefQ" height="1" width="1" alt=""/>]]></content:encoded>
      </item>
      <item>
         <title>CIRM encourages Parkinson's group</title>
         <link>http://www.sandiegouniontribune.com/news/2015/sep/24/cirm-parkinsons-applications/</link>
         <description>State stem cell agency CIRM speeds &quot;translational&quot; project review schedule.</description>
         <guid isPermaLink="false">http://www.sandiegouniontribune.com/news/2015/sep/24/cirm-parkinsons-applications/</guid>
         <pubDate>Fri, 25 Sep 2015 01:46:17 +0000</pubDate>
      </item>
      <item>
         <title>Stem cell manufacturing now ready</title>
         <link>http://www.sandiegouniontribune.com/news/2015/sep/24/induced-pluripotent-stem-cell-lonza-manufacturing/</link>
         <description>Biotech Lonza provides the basic technology gratis. Customers can also pay for service.</description>
         <guid isPermaLink="false">http://www.sandiegouniontribune.com/news/2015/sep/24/induced-pluripotent-stem-cell-lonza-manufacturing/</guid>
         <pubDate>Thu, 24 Sep 2015 16:00:00 +0000</pubDate>
      </item>
      <item>
         <title>Mobile app records our erratic eating habits</title>
         <link>http://www.salk.edu/news/pressrelease_details.php?press_id=2116</link>
         <description>&lt;p&gt;
LA JOLLA&amp;#8211;Breakfast, lunch and dinner? For too many of us, the three meals of the day go more like: morning meeting pastry, mid-afternoon energy drink and midnight pizza. In &lt;em&gt;&lt;a rel=&quot;nofollow&quot; target=&quot;_blank&quot; href=&quot;http://www.cell.com/cell-metabolism/abstract/S1550-4131(15)00462-3&quot;&gt;Cell Metabolism&lt;/a&gt;&lt;/em&gt; on September 24, Salk Institute scientists present daily food and beverage intake data collected from over 150 participants of a mobile research app over three weeks. They show that a majority of people eat for 15 hours or longer, with less than a quarter of the day&amp;rsquo;s calories being consumed before noon and over a third consumed after 6 p.m.</description>
         <guid isPermaLink="false">http://www.salk.edu/news/pressrelease_details.php?press_id=2116</guid>
         <pubDate>Thu, 24 Sep 2015 00:00:00 +0000</pubDate>
      </item>
      <item>
         <title>Taking blood pressure drugs at bedtime lowers diabetes risk</title>
         <link>http://www.sandiegouniontribune.com/news/2015/sep/23/blood-pressure-bedtime-diabetes-risk/</link>
         <description>Taking blood pressure meds at night halves type 2 diabetes risk, in Spanish study.</description>
         <guid isPermaLink="false">http://www.sandiegouniontribune.com/news/2015/sep/23/blood-pressure-bedtime-diabetes-risk/</guid>
         <pubDate>Wed, 23 Sep 2015 23:17:20 +0000</pubDate>
      </item>
      <item>
         <title>Shkreli Implodes And Provides Hillary A Perfect Medicare Moment</title>
         <link>http://feedproxy.google.com/~r/Xconomy_San_Diego_Life_Sciences/~3/LhCLmEimKRg/</link>
         <guid isPermaLink="false">http://www.xconomy.com/?p=309656</guid>
         <pubDate>Wed, 23 Sep 2015 22:46:31 +0000</pubDate>
         <content:encoded><![CDATA[It was already a good political time for Hillary Clinton to unveil her plan to control the cost of prescription drugs. Martin Shkreli made it perfect. As you&#8217;ve probably heard by now, the...<br/>
<br/>
[[Click headline to continue reading.]]<img src="http://feeds.feedburner.com/~r/Xconomy_San_Diego_Life_Sciences/~4/LhCLmEimKRg" height="1" width="1" alt=""/>]]></content:encoded>
      </item>
      <item>
         <title>Drug reduces cirrhosis signs</title>
         <link>http://www.sandiegouniontribune.com/news/2015/sep/23/emricasan-liver-conatus-cirrhosis/</link>
         <description>Conatus' liver drug emericasan reduces key indicator of damage from cirrhosis.</description>
         <guid isPermaLink="false">http://www.sandiegouniontribune.com/news/2015/sep/23/emricasan-liver-conatus-cirrhosis/</guid>
         <pubDate>Wed, 23 Sep 2015 20:01:00 +0000</pubDate>
      </item>
      <item>
         <title>Venter's HLI offers genomic health testing</title>
         <link>http://www.sandiegouniontribune.com/news/2015/sep/22/human-longevity-insurance/</link>
         <description>San Diego company to offer genomic sequencing for $250 in UK, South Africa.</description>
         <guid isPermaLink="false">http://www.sandiegouniontribune.com/news/2015/sep/22/human-longevity-insurance/</guid>
         <pubDate>Wed, 23 Sep 2015 01:01:41 +0000</pubDate>
      </item>
      <item>
         <title>New grant will fund collaborative effort to build reproducible assays to model autism</title>
         <link>http://www.salk.edu/news/pressrelease_details.php?press_id=2115</link>
         <description>&lt;p&gt;
LA JOLLA-&lt;a rel=&quot;nofollow&quot; target=&quot;_blank&quot; href=&quot;http://www.nih.gov/&quot;&gt;The National Institutes of Health&lt;/a&gt; has awarded a $13 million grant over five years to develop and disseminate new stem cell-based technologies and assays for studying &lt;a rel=&quot;nofollow&quot; target=&quot;_blank&quot; href=&quot;http://www.salk.edu/ra/autism.html&quot;&gt;autism spectrum disorder&lt;/a&gt; (ASD) and other mental health diseases to a consortium of researchers at the &lt;a rel=&quot;nofollow&quot; target=&quot;_blank&quot; href=&quot;https://ucsd.edu/&quot;&gt;University of California, San Diego&lt;/a&gt; and the Salk Institute for Biological Studies, working in tandem with leaders in the biotechnology sector.</description>
         <guid isPermaLink="false">http://www.salk.edu/news/pressrelease_details.php?press_id=2115</guid>
         <pubDate>Wed, 23 Sep 2015 00:00:00 +0000</pubDate>
      </item>
      <item>
         <title>Tatyana Sharpee named to NSF team trying to crack olfactory code</title>
         <link>http://www.salk.edu/news/pressrelease_details.php?press_id=2114</link>
         <description>&lt;p&gt;
LA JOLLA&amp;#8211;Since the early 19th century, scientists have worked to unravel the mystery of olfaction, our sense of smell.</description>
         <guid isPermaLink="false">http://www.salk.edu/news/pressrelease_details.php?press_id=2114</guid>
         <pubDate>Wed, 23 Sep 2015 00:00:00 +0000</pubDate>
      </item>
      <item>
         <title>Can your sense of smell predict when you'll die?</title>
         <link>http://www.salk.edu/news/pressrelease_details.php?press_id=2112</link>
         <description>&lt;p&gt;LA JOLLA&amp;#8211;By measuring how worms move toward an appealing, food-like scent, researchers at the Salk Institute were able to predict whether the worms would be long-lived. The finding, published September 22, 2015 in the journal &lt;a rel=&quot;nofollow&quot; target=&quot;_blank&quot; href=&quot;http://dx.doi.org/10.7554/eLife.10181&quot;&gt;&lt;em&gt;eLife&lt;/em&gt;&lt;/a&gt;, shows how nematodes (&lt;em&gt;Caenorhabditis elegans&lt;/em&gt;) process information about the environment and how circuits in the brain change as an animal ages.</description>
         <guid isPermaLink="false">http://www.salk.edu/news/pressrelease_details.php?press_id=2112</guid>
         <pubDate>Tue, 22 Sep 2015 00:00:00 +0000</pubDate>
      </item>
      <item>
         <title>Aspirin relative might help Alzheimer's</title>
         <link>http://www.sandiegouniontribune.com/news/2015/sep/21/salsalate-tau-alzheimer/</link>
         <description>Salsalate, an old drug, reduces toxic tangles of tau protein in mice, study finds.</description>
         <guid isPermaLink="false">http://www.sandiegouniontribune.com/news/2015/sep/21/salsalate-tau-alzheimer/</guid>
         <pubDate>Mon, 21 Sep 2015 15:00:00 +0000</pubDate>
      </item>
      <item>
         <title>Data From New Studies Confirm In Vitro Potency of VIBATIV(R) (Telavancin) Against Gram-Positive Bacteria, Including MRSA</title>
         <link>http://feeds.mwnewsroom.com/article/rss?id=1985913</link>
         <description>Data From New Studies Confirm In Vitro Potency of VIBATIV(R) (Telavancin) Against Gram-Positive Bacteria, Including MRSA</description>
         <guid isPermaLink="false"></guid>
         <pubDate>Mon, 21 Sep 2015 12:05:00 +0000</pubDate>
      </item>
      <item>
         <title>Three Salk faculty honored as recipients of endowed chairs</title>
         <link>http://www.salk.edu/news/pressrelease_details.php?press_id=2113</link>
         <description>&lt;p&gt;
Salk scientists &lt;a rel=&quot;nofollow&quot; target=&quot;_blank&quot; href=&quot;http://www.salk.edu/faculty/reynolds.html&quot;&gt;John Reynolds&lt;/a&gt;, &lt;a rel=&quot;nofollow&quot; target=&quot;_blank&quot; href=&quot;http://www.salk.edu/faculty/bellugi.html&quot;&gt;Ursula Bellugi&lt;/a&gt; and &lt;a rel=&quot;nofollow&quot; target=&quot;_blank&quot; href=&quot;http://www.salk.edu/faculty/saghatelian.html&quot;&gt;Alan Saghatelian&lt;/a&gt; have been honored with the dedication of three endowed chairs in acknowledgement of their outstanding contributions and dedication to scientific research. Bellugi and Reynolds were named inaugural holders of the Salk Founders&amp;rsquo; Chair and Fiona and Sanjay Jha Chair in Neuroscience, respectively. Saghatalian was named holder of the Dr. Frederik Paulsen Chair in Neuroscience.</description>
         <guid isPermaLink="false">http://www.salk.edu/news/pressrelease_details.php?press_id=2113</guid>
         <pubDate>Mon, 21 Sep 2015 00:00:00 +0000</pubDate>
      </item>
      <item>
         <title>Parkinson's stem cell project seeks funding</title>
         <link>http://www.sandiegouniontribune.com/news/2015/sep/20/cirm-parkinsons-summit4stemcell/</link>
         <description>What does it take to get potential stem cell therapies funded? One group's story.</description>
         <guid isPermaLink="false">http://www.sandiegouniontribune.com/news/2015/sep/20/cirm-parkinsons-summit4stemcell/</guid>
         <pubDate>Sun, 20 Sep 2015 22:58:05 +0000</pubDate>
      </item>
      <item>
         <title>UCSD to study germs as crime scene evidence</title>
         <link>http://www.sandiegouniontribune.com/news/2015/sep/18/ucsd-study-germs-crime-microbial-evidence/</link>
         <description>Scientists at UC San Diego will be exploring the next big thing in crime scene analysis — our germs.</description>
         <guid isPermaLink="false">http://www.sandiegouniontribune.com/news/2015/sep/18/ucsd-study-germs-crime-microbial-evidence/</guid>
         <pubDate>Sat, 19 Sep 2015 00:38:54 +0000</pubDate>
      </item>
      <item>
         <title>Pedal the Cause: Team SBP pedals for Luke</title>
         <link>http://beaker.sbpdiscovery.org/2015/09/pedal-the-cause-team-sbp-pedals-for-luke/</link>
         <guid isPermaLink="false">http://beaker.sbpdiscovery.org/?p=42949</guid>
         <pubDate>Fri, 18 Sep 2015 20:17:21 +0000</pubDate>
         <content:encoded><![CDATA[<img width="564" height="377" src="http://beaker.sbpdiscovery.org/wp-content/uploads/2015/09/Luke-and-Team-SBP-at-Birch-Aquarium-4091.jpg" class="attachment-feed-four-story wp-post-image" alt="Luke Sybert tours the Birch Aquarium with SBP&#039;s Pedal the Cause team"/>Luke Sybert is a cancer patient at Rady Children's Hospital.  Team SBP is riding for Luke in the 2015 Pedal the Cause event.]]></content:encoded>
      </item>
      <item>
         <title>Pedal the Cause rides against cancer</title>
         <link>http://www.sandiegouniontribune.com/news/2015/sep/18/pedal-cause-cancer-families/</link>
         <description>San Diego's Pedal the Cause fundraiser for local cancer research happens this weekend.</description>
         <guid isPermaLink="false">http://www.sandiegouniontribune.com/news/2015/sep/18/pedal-cause-cancer-families/</guid>
         <pubDate>Fri, 18 Sep 2015 18:11:08 +0000</pubDate>
      </item>
      <item>
         <title>2 top scientists to lead Scripps Research</title>
         <link>http://www.sandiegouniontribune.com/news/2015/sep/18/scripps-research-institute/</link>
         <description>After nearly yearlong search, Peter Schultz named TSRI CEO, with Steve Kay as president.</description>
         <guid isPermaLink="false">http://www.sandiegouniontribune.com/news/2015/sep/18/scripps-research-institute/</guid>
         <pubDate>Fri, 18 Sep 2015 17:01:00 +0000</pubDate>
      </item>
      <item>
         <title>West Coast Bio Roundup: Google/Insel, SeaGen, Avalon, Alector &amp; More</title>
         <link>http://feedproxy.google.com/~r/Xconomy_San_Diego_Life_Sciences/~3/23EPhxtEH2E/</link>
         <guid isPermaLink="false">http://www.xconomy.com/?p=309321</guid>
         <pubDate>Fri, 18 Sep 2015 11:31:40 +0000</pubDate>
         <content:encoded><![CDATA[It&#8217;s not specific to the West Coast, but anyone who needs to catch up on the week&#8217;s events should read the British Medical Journal&#8217;s re-analysis of a long-criticized study, dubbed...<br/>
<br/>
[[Click headline to continue reading.]]<img src="http://feeds.feedburner.com/~r/Xconomy_San_Diego_Life_Sciences/~4/23EPhxtEH2E" height="1" width="1" alt=""/>]]></content:encoded>
      </item>
      <item>
         <title>Reality Check: Cancer Experts Discuss Hurdles Facing CAR-T Therapy</title>
         <link>http://feedproxy.google.com/~r/Xconomy_San_Diego_Life_Sciences/~3/v7wU--cdDv8/</link>
         <guid isPermaLink="false">http://www.xconomy.com/?p=309310</guid>
         <pubDate>Fri, 18 Sep 2015 10:00:42 +0000</pubDate>
         <content:encoded><![CDATA[There’s a lot of excitement these days about a type of cellular immunotherapy known as CAR-T, a method of modifying peoples’ immune cells to fight cancer. But you could also fill a book listing all...<br/>
<br/>
[[Click headline to continue reading.]]<img src="http://feeds.feedburner.com/~r/Xconomy_San_Diego_Life_Sciences/~4/v7wU--cdDv8" height="1" width="1" alt=""/>]]></content:encoded>
      </item>
      <item>
         <title>SDSU to specialize in mobile health sensors</title>
         <link>http://www.sandiegouniontribune.com/news/2015/sep/17/mHealth-sensors-SDSU/</link>
         <description>New institute broadens school's reach in personalized medicine.</description>
         <guid isPermaLink="false">http://www.sandiegouniontribune.com/news/2015/sep/17/mHealth-sensors-SDSU/</guid>
         <pubDate>Thu, 17 Sep 2015 19:40:33 +0000</pubDate>
      </item>
      <item>
         <title>Not all organs age alike</title>
         <link>http://www.salk.edu/news/pressrelease_details.php?press_id=2111</link>
         <description>&lt;p&gt;
LA JOLLA&amp;#8211;Aging is typically thought of as the gradual decline of the whole body, but new research shows that age affects organs in strikingly different ways. A study published September 17, 2015 in &lt;em&gt;&lt;a rel=&quot;nofollow&quot; target=&quot;_blank&quot; href=&quot;http://www.cell.com/cell-systems/abstract/S2405-4712(15)00110-6&quot;&gt;Cell Systems&lt;/a&gt;&lt;/em&gt; provides the first comprehensive view of how cellular proteins age in different organs, revealing major differences between the liver and brain in young and old rats. The findings suggest that how an organ ages may depend on its unique cellular properties and its physiological function in the body.</description>
         <guid isPermaLink="false">http://www.salk.edu/news/pressrelease_details.php?press_id=2111</guid>
         <pubDate>Thu, 17 Sep 2015 00:00:00 +0000</pubDate>
      </item>
      <item>
         <title>Alector Raises $32M For Immune-Based Neuro Drug Development</title>
         <link>http://feedproxy.google.com/~r/Xconomy_San_Diego_Life_Sciences/~3/HwYQ2FnQ4VE/</link>
         <guid isPermaLink="false">http://www.xconomy.com/?p=309213</guid>
         <pubDate>Wed, 16 Sep 2015 22:05:38 +0000</pubDate>
         <content:encoded><![CDATA[Researchers around the world have explored the ties between the immune system and devastating neurodegenerative diseases such as Alzheimer&#8217;s. San Francisco biotech Alector wants to exploit...<br/>
<br/>
[[Click headline to continue reading.]]<img src="http://feeds.feedburner.com/~r/Xconomy_San_Diego_Life_Sciences/~4/HwYQ2FnQ4VE" height="1" width="1" alt=""/>]]></content:encoded>
      </item>
      <item>
         <title>With Revamped Trial, Aerie, Glaucoma Drug Bounce Back</title>
         <link>http://feedproxy.google.com/~r/Xconomy_San_Diego_Life_Sciences/~3/P_wgttBTCe8/</link>
         <guid isPermaLink="false">http://www.xconomy.com/?p=309199</guid>
         <pubDate>Wed, 16 Sep 2015 21:56:01 +0000</pubDate>
         <content:encoded><![CDATA[Aerie Pharmaceuticals took a beating from investors earlier this year when its glaucoma drug failed the first of a few Phase 3 trials. But today the company has bounced back, thanks to a helping hand...<br/>
<br/>
[[Click headline to continue reading.]]<img src="http://feeds.feedburner.com/~r/Xconomy_San_Diego_Life_Sciences/~4/P_wgttBTCe8" height="1" width="1" alt=""/>]]></content:encoded>
      </item>
      <item>
         <title>Platelet membranes improve drug delivery</title>
         <link>http://www.sandiegouniontribune.com/news/2015/sep/16/nanoparticles-zhang-drug-delivery/</link>
         <description>Hiding drugs inside platelet-covered nanoparticles increases their effectiveness.</description>
         <guid isPermaLink="false">http://www.sandiegouniontribune.com/news/2015/sep/16/nanoparticles-zhang-drug-delivery/</guid>
         <pubDate>Wed, 16 Sep 2015 17:00:00 +0000</pubDate>
      </item>
      <item>
         <title>Obama Nominates Duke Veteran Rob Califf To Lead FDA</title>
         <link>http://feedproxy.google.com/~r/Xconomy_San_Diego_Life_Sciences/~3/YkWEe0Nha_Q/</link>
         <guid isPermaLink="false">http://www.xconomy.com/?p=309074</guid>
         <pubDate>Tue, 15 Sep 2015 23:38:38 +0000</pubDate>
         <content:encoded><![CDATA[President Obama has nominated cardiologist Rob Califf to be the next head of the Food and Drug Administration, replacing the outgoing Margaret &#8220;Peggy&#8221; Hamburg. The nomination is no...<br/>
<br/>
[[Click headline to continue reading.]]<img src="http://feeds.feedburner.com/~r/Xconomy_San_Diego_Life_Sciences/~4/YkWEe0Nha_Q" height="1" width="1" alt=""/>]]></content:encoded>
      </item>
      <item>
         <title>What's that sound?</title>
         <link>http://www.sandiegouniontribune.com/news/2015/sep/15/salk-sonogenetics-chalasani-elegans/</link>
         <description>New technology for studying the brain developed by Salk Institute-led science team.</description>
         <guid isPermaLink="false">http://www.sandiegouniontribune.com/news/2015/sep/15/salk-sonogenetics-chalasani-elegans/</guid>
         <pubDate>Tue, 15 Sep 2015 15:45:32 +0000</pubDate>
      </item>
      <item>
         <title>American Copycats: Can Biosimilars Catch On And Cut Costs In U.S.?</title>
         <link>http://feedproxy.google.com/~r/Xconomy_San_Diego_Life_Sciences/~3/sM4FMPFQ564/</link>
         <guid isPermaLink="false">http://www.xconomy.com/?p=308992</guid>
         <pubDate>Tue, 15 Sep 2015 10:30:11 +0000</pubDate>
         <content:encoded><![CDATA[Americans need to spend less on healthcare. Anyone disagree? No country spends like we do: 17 percent of our gross domestic product the past four years, in fact, according to the World Bank. No other...<br/>
<br/>
[[Click headline to continue reading.]]<img src="http://feeds.feedburner.com/~r/Xconomy_San_Diego_Life_Sciences/~4/sM4FMPFQ564" height="1" width="1" alt=""/>]]></content:encoded>
      </item>
      <item>
         <title>In first, Salk scientists use sound waves to control brain cells</title>
         <link>http://www.salk.edu/news/pressrelease_details.php?press_id=2110</link>
         <description>&lt;p&gt;
LA JOLLA&amp;#8211;Salk scientists have developed a new way to selectively activate brain, heart, muscle and other cells using ultrasonic waves. The new technique, dubbed sonogenetics, has some similarities to the burgeoning use of light to activate cells in order to better understand the brain.</description>
         <guid isPermaLink="false">http://www.salk.edu/news/pressrelease_details.php?press_id=2110</guid>
         <pubDate>Tue, 15 Sep 2015 00:00:00 +0000</pubDate>
      </item>
      <item>
         <title>Qualcomm Buys Capsule to Unite Health Data Across Hospital &amp; Home</title>
         <link>http://feedproxy.google.com/~r/Xconomy_San_Diego_Life_Sciences/~3/yL92JYAasSY/</link>
         <guid isPermaLink="false">http://www.xconomy.com/?p=308983</guid>
         <pubDate>Mon, 14 Sep 2015 22:39:13 +0000</pubDate>
         <content:encoded><![CDATA[Qualcomm (NASDAQ: QCOM) said its Qualcomm Life subsidiary has acquired Capsule Technologie, an Andover, MA-based healthtech systems company with more than 1,900 hospital customers in 38 countries....<br/>
<br/>
[[Click headline to continue reading.]]<img src="http://feeds.feedburner.com/~r/Xconomy_San_Diego_Life_Sciences/~4/yL92JYAasSY" height="1" width="1" alt=""/>]]></content:encoded>
      </item>
      <item>
         <title>Pharma Plays The “Value” Card: Drug Spending Then And Now</title>
         <link>http://feedproxy.google.com/~r/Xconomy_San_Diego_Life_Sciences/~3/prqv816GxZ4/</link>
         <guid isPermaLink="false">http://www.xconomy.com/?p=308744</guid>
         <pubDate>Mon, 14 Sep 2015 04:01:15 +0000</pubDate>
         <content:encoded><![CDATA[Dr. John Lechleiter, the CEO of Eli Lilly, recently attempted to debunk five “Big Myths” about Big Pharma. As he wrote, “Only about 10 cents of every U.S. healthcare dollar is spent on retail...<br/>
<br/>
[[Click headline to continue reading.]]<img src="http://feeds.feedburner.com/~r/Xconomy_San_Diego_Life_Sciences/~4/prqv816GxZ4" height="1" width="1" alt=""/>]]></content:encoded>
      </item>
      <item>
         <title>San Diego's shows path to biotech success</title>
         <link>http://www.sandiegouniontribune.com/news/2015/sep/13/what-makes-a-biotech-hub-la/</link>
         <description>Biotech community emerged from a long-term vision, prime land, people and collaboration.</description>
         <guid isPermaLink="false">http://www.sandiegouniontribune.com/news/2015/sep/13/what-makes-a-biotech-hub-la/</guid>
         <pubDate>Sun, 13 Sep 2015 18:39:34 +0000</pubDate>
      </item>
      <item>
         <title>Organizing around the brain</title>
         <link>http://www.sandiegouniontribune.com/news/2015/sep/12/brain-consortium-precious/</link>
         <description>New San Diego alliance of brain researchers, public convenes first event.</description>
         <guid isPermaLink="false">http://www.sandiegouniontribune.com/news/2015/sep/12/brain-consortium-precious/</guid>
         <pubDate>Sun, 13 Sep 2015 00:52:02 +0000</pubDate>
      </item>
      <item>
         <title>Ardent Salk supporter Edwin Hunter appointed to Institute board of trustees</title>
         <link>http://www.salk.edu/news/pressrelease_details.php?press_id=2109</link>
         <description>&lt;p&gt;LA JOLLA&amp;#8211;The Salk Institute is pleased to announce the election of &lt;a rel=&quot;nofollow&quot; target=&quot;_blank&quot; href=&quot;http://www.hhslawfirm.com/attorney/edwin-k-hunter&quot;&gt;Edwin K. Hunter&lt;/a&gt;, a longtime supporter of the Institute and president of &lt;a rel=&quot;nofollow&quot; target=&quot;_blank&quot; href=&quot;http://www.hhslawfirm.com/&quot;&gt;Hunter, Hunter &amp; Sonnier, LLC&lt;/a&gt;, to its Board of Trustees. The Board voted on the appointment August 28.</description>
         <guid isPermaLink="false">http://www.salk.edu/news/pressrelease_details.php?press_id=2109</guid>
         <pubDate>Fri, 11 Sep 2015 00:00:00 +0000</pubDate>
      </item>
      <item>
         <title>West Coast Biotech Roundup: Tandem, Pathway Genomics, Denali &amp; More</title>
         <link>http://feedproxy.google.com/~r/Xconomy_San_Diego_Life_Sciences/~3/zHqT95xOMNE/</link>
         <guid isPermaLink="false">http://www.xconomy.com/?p=308700</guid>
         <pubDate>Thu, 10 Sep 2015 11:40:21 +0000</pubDate>
         <content:encoded><![CDATA[Now that Labor Day is over, the innovation-driven life sciences editors at Xconomy can pass along the really important news&#8212;Billboard magazine’s final Songs of the Summer chart. As you may...<br/>
<br/>
[[Click headline to continue reading.]]<img src="http://feeds.feedburner.com/~r/Xconomy_San_Diego_Life_Sciences/~4/zHqT95xOMNE" height="1" width="1" alt=""/>]]></content:encoded>
      </item>
      <item>
         <title>Errant gene turns cells into mobile cancer factories</title>
         <link>http://www.salk.edu/news/pressrelease_details.php?press_id=2106</link>
         <description>&lt;style&gt;


#nivoSlider{
min-height:367px;background-color:black;}


.nivo-caption{
}

.imageCaption530 .nivo-html-caption{
font-size:11px;}
.imageCaption530 .nivo-caption{
line-height:16px;background:#00648f;
}

.imageCaption530 .nivo-caption a{
color:white;text-decoration:underline;}

.imageCaption530 .nivo-controlNav {
}


&lt;/style&gt;



&lt;p&gt;

LA JOLLA&amp;#8211;A single stem cell has the potential to generate an animal made of millions of different types of cells. Some &lt;a rel=&quot;nofollow&quot; target=&quot;_blank&quot; href=&quot;http://www.salk.edu/ra/cancer.html&quot;&gt;cancers&lt;/a&gt; contain stem-like but abnormal cells that can act like   mini factories to rapidly churn out not only more copies of themselves, but also variants that are able to better survive in the challenging and changing environments to which cancers are exposed.   Worse still, these stem cell-like cancers can spread to other tissues in the body, causing metastasis.</description>
         <guid isPermaLink="false">http://www.salk.edu/news/pressrelease_details.php?press_id=2106</guid>
         <pubDate>Thu, 10 Sep 2015 00:00:00 +0000</pubDate>
      </item>
   </channel>
</rss>
<!-- fe3.yql.bf1.yahoo.com compressed/chunked Thu Oct  1 22:52:08 UTC 2015 -->
